Home » Newsletters » BioWorld

BioWorld

March 28, 2000

View Archived Issues

BioStratum Closes $28M Financing For Phase II Trial

Swedish Firm In Agreement To Buy U.S.-Based Novalon Pharmaceutical

Biotech Strategies For Taking Advantage of Pharma's Failures

CTI Aims To Raise $88M, Plans NDA This Month

Other News To Note

UTC's Uniprost Positive In Early Pivotal Findings

Millennium, Caliper Collaborate To Develop Microfluidics Tools

From Working With Genes To Marketing Products: The Genomics Future

Immunologists Strive To Make Organ Transplantation Kindlier, Gentler - In Mice, Monkeys, Pigs